FDA approves MenQuadfi meningococcal vaccine for children 6 weeks or older
The approved indication now includes children down to 6 weeks of age to protect against invasive meningococcal disease via serogroups A, C, W, and Y.
Weeky review: COVID-19 vaccine approved, framework laid out, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Nicotine pouch use nearly doubles among US high school students
A recently published study found sharp increase in the use of nicotine pouches among US high school students, with usage nearly doubling from 2023 to 2024.
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Our editor-in-chief Tina Tan, MD, reacts to a new FDA COVID-19 framework that will limit eligibility for seasonal vaccination in pediatrics.
Jennifer Soung, MD, reacts to the FDA approval of roflumilast foam 0.3%
Roflumilast foam 0.3% trial investigator Jennifer Soung, MD, joined us to discuss the importance of this newly FDA-approved topical treatment for patients aged 12 years or older with scalp and body psoriasis.
FDA approves roflumilast foam 0.3% for scalp, body psoriasis
The once-daily, steroid-free topical is now approved to treat plaque psoriasis of the scalp and body in patients aged 12 years and older.
Social media potentially linked to depression in children
“These findings provide evidence that social media may be contributing to the development of depressive symptoms,” said Jason M. Nagata, MD, MSc.
Supporting mental health in pediatric primary care with Victor Carrion, MD
Victor Carrion, MD, emphasizes how pediatricians can monitor and support mental health in youth while navigating limited access to specialized care.
FDA approves Jivi for patients aged 7 years and older with hemophilia A
The expanded indication follows original approval in August 2018 for use in previously-treated patients 12 years and older.
Maternal RSV vaccine data reveal uptake disparities
These findings come as many health care professionals still report limited confidence and inconsistent practices regarding RSV immunization discussions.
Hormonal birth control TikTok videos often misinform viewers, study finds
Most videos on TikTok regarding hormonal contraception were misleading, according to a study presented at the 2025 ACOG Annual Clinical and Scientific Meeting.
Weekly review: Multiple FDA action items, USPSTF recommendation, and more
Albuterol-budesonide yields lower asthma exacerbation risk vs albuterol alone
Albuterol-budesonide (Airsupra; AstraZeneca) resulted in a 47% reduction in severe exacerbations in mild asthma vs albuterol alone.
FDA approves NVX-CoV2705 COVID-19 vaccine
NVX-CoV2705 is indicated for individuals aged 12 to 64 years with an underlying condition that poses high risk for severe COVID-19 outcomes.
Age, condition-specific risks for severe RSV disease in children
Severe RSV disease in 2022–2023 was most likely to occur in infants under 6 months and older children with pulmonary or neurologic conditions.
Discussing social media and potential nutrition impacts with Colleen Sloan, PA-C, RDN
Colleen Sloan, PA-C, RDN, highlights what she is seeing in practice related to screen time, devices, and social media and impacts on nutrition.
Duchenne muscular dystrophy gene therapy demonstrates improved motor functions
Delandistrogene moxeparvovec-rokl (ELEVIDYS) showed significant motor function improvements in 8- to 9-year-old Duchenne muscular dystrophy patients in part 2 of the phase 3 EMBARK study.
Connecting families to music therapy, with Jenna Marcovitz, MA
Music therapist Jenna Marcovitz discusses the role of pediatricians in making timely referrals to music therapy to support whole-child health.
Phase 3 data show effectiveness of somapacitan in children with growth disorders
Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates.
USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit
The nearly 4000 cases in 2023 were the highest number reported in over 30 years, the Task Force stated.
INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients
Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial.
FDA accepts NDA for berotralstat in HAE patients aged 2 to 11 years
The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO).
FDA seeks to remove ingestible fluoride products for children
The administration has set a goal date of October 31 to complete a safety review, public comment period, and to take "appropriate action" in efforts to remove products from the market.
FDA starts review of nutrients in infant formula
According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data."
FDA approves pediatric indication for Optison ultrasound enhancing agent
This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare.
Maternal avocado consumption linked to reduced infant food allergy risk
Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months.
FDA clears EN-374 therapy application for X-linked chronic granulomatous disease
The in vivo hematopoietic stem cell-directed therapy received rare pediatric disease and orphan drug designations earlier this year.
Frequent perinatal antibiotic use and impaired lung function in preterm-born children
"Early identification of high-risk neonates may enable targeted strategies to support respiratory health," stated the study investigators.
Weekly review: Neffy 1 mg available, new case study, and more
Jenna Marcovitz, MA, explains how music therapy helps in pediatric care
In this video interview, Jenna Marcovitz, MA, MT-BC, CCLS, RMT, provides insight to music therapy and how it can benefit a wide range of pediatric patients.
